Tai Junhu, Han Munsoo, Lee Dabin, Park Il-Ho, Lee Sang Hag, Kim Tae Hoon
Department of Otorhinolaryngology-Head & Neck Surgery, College of Medicine, Korea University, Seoul 02841, Korea.
Pharmaceutics. 2022 May 17;14(5):1073. doi: 10.3390/pharmaceutics14051073.
Nasal drug delivery is advantageous when compared with other routes of drug delivery as it avoids the hepatic first-pass effect, blood-brain barrier penetration, and compliance issues with parenteral administration. However, nasal administration also has some limitations, such as its low bioavailability due to metabolism on the mucosal surface, and irreversible damage to the nasal mucosa due to the ingredients added into the formula. Moreover, the method of nasal administration is not applicable to all drugs. The current review presents the nasal anatomy and mucosal environment for the nasal delivery of vaccines and drugs, as well as presents various methods for enhancing nasal absorption, and different drug carriers and delivery devices to improve nasal drug delivery. It also presents future prospects on the nasal drug delivery of vaccines and drugs.
与其他给药途径相比,鼻腔给药具有优势,因为它避免了肝脏首过效应、血脑屏障穿透以及注射给药的顺应性问题。然而,鼻腔给药也有一些局限性,例如由于在粘膜表面的代谢导致生物利用度低,以及由于配方中添加的成分对鼻粘膜造成不可逆损伤。此外,鼻腔给药方法并不适用于所有药物。本综述介绍了用于疫苗和药物鼻腔给药的鼻腔解剖结构和粘膜环境,以及各种增强鼻腔吸收的方法,和不同的药物载体及给药装置以改善鼻腔给药。它还展示了疫苗和药物鼻腔给药的未来前景。